California Public Employees Retirement System’s ADC Therapeutics ADCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-73,925
Closed -$1.8M 1552
2021
Q1
$1.8M Sell
73,925
-15,805
-18% -$458K ﹤0.01% 2073
2020
Q4
$2.87M Buy
89,730
+61,700
+220% +$2.02M ﹤0.01% 1771
2020
Q3
$925K Buy
+28,030
New +$1.21M ﹤0.01% 2336

Other funds holding ADCT

California Public Employees Retirement System's ADCT Position: Q2 2021 in Review

California Public Employees Retirement System sold out of ADC Therapeutics (ADCT) in Q2 2021, closing a stake of 73,925 shares — an estimated $1.8M sold.

California Public Employees Retirement System first reported a position in ADCT in Q3 2020 and held it in 3 quarters. The position peaked at $2.87M in Q4 2020. 56 funds tracked by Wall St. Rank hold ADCT as of Q2 2021.

  • California Public Employees Retirement System reported no remaining ADC Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 73,925 ADC Therapeutics shares in Q2 2021, an estimated $1.8M.
  • California Public Employees Retirement System first reported a position in ADC Therapeutics in Q3 2020 and held it in 3 quarters.
  • California Public Employees Retirement System's ADC Therapeutics position peaked at $2.87M in Q4 2020.
  • 56 funds tracked by Wall St. Rank held ADC Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.